Kaifeng Investment
凯风投资
Kaifeng Investment (凯风创投 / 凯风投资) is a Chinese venture capital firm that appears as a co-investor alongside major funds in hard-tech and biotech deals. The corpus shows it participating in rounds led by 5Y Capital (五源资本), including as a follow-on investor in LifeTech Scientific's 2020 RMB 1.2 billion round , in Aikai Biotech's rapid 2021-2022 series of fundraises totaling over RMB 300 million , and in automotive mmWave radar chip startup Muyewei's 2023 RMB 100 million Pre-A round . More recently, it co-invested in Aikelian Biotechnology's $68.7 million combined founding and extension rounds in 2025-2026 alongside Sequoia China and others . elsewhere's corpus does not contain details on its founding, team, or fund scale.
AI-generated — may contain errors, please verify.
Coverage
5Y News｜Aikelian Biotechnology Completes $68.7 Million Funding Round
Aikelian Biotech has successfully completed an oversubscribed $68.7 million funding round.
五源资本·May, Where Hope Springs Eternal | 5Y News Monthly
The big news from last month.
五源资本·5Y News | Automotive-grade mmWave Radar Chip Company "Muyewei" Closes 100 Million Yuan Pre-A Round
Building a smarter future.
五源资本·April: Imagination Is the Courage with Which We Face the World | 5Y News Monthly
The big news from last month.
五源资本·5Y News | Aikai Biotech Completes Three Funding Rounds in Its First Year
Innovate from the source.
五源资本·Morningside-backed LifeTech Scientific raises over RMB 1.2 billion in new funding round | Light Moments
China's new drug R&D is undergoing a "Cambrian explosion." The industry's underlying infrastructure for pharmaceutical innovation is one of the core sectors we're tracking in healthcare.
五源资本·
